HK Stock Market Move | CHAOJU EYE CARE (02219) fell over 7% as mid-term net profit attributable to the parent company decreased by 16.65% year-on-year, with revenue increasing by 1.78%.

CHAOJU EYE CARE (02219) fell more than 7%, and as of the time of writing, it has dropped 7.28%, trading at HK$2.355, with a transaction volume of HK$4.9074 million. In terms of news, CHAOJU EYE CARE reported its mid-term results for 2026, with the group achieving revenues of 711 million yuan (all figures in the same unit), an increase of 1.78% year-on-year; profit attributable to the shareholders of the parent company was 94.72 million yuan, a decrease of 16.65% year-on-year. During the period, revenue from basic ophthalmic services was 324 million yuan, down 4.1% year-on-year, primarily due to tightening national medical insurance pricing policies; revenue from consumer ophthalmic services increased by 3.7% year-on-year to 373 million yuan, mainly due to the company optimizing its surgical structure and providing higher-end surgical options for patients. The company gradually introduced SMILE-PRO equipment starting from May 2025 to improve the service pricing system, resulting in a simultaneous increase in both volume and price.